Bing Wen

413 total citations
21 papers, 300 citations indexed

About

Bing Wen is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Bing Wen has authored 21 papers receiving a total of 300 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Bing Wen's work include Microbial metabolism and enzyme function (3 papers), Cellular Mechanics and Interactions (3 papers) and Autophagy in Disease and Therapy (3 papers). Bing Wen is often cited by papers focused on Microbial metabolism and enzyme function (3 papers), Cellular Mechanics and Interactions (3 papers) and Autophagy in Disease and Therapy (3 papers). Bing Wen collaborates with scholars based in China, New Zealand and Israel. Bing Wen's co-authors include En‐Min Li, Li‐Yan Xu, Yue Wu, Juan Chen, Ning‐hua Wu, Qingjie Chen, Juan Chen, Weijian Hang, Jiehui Chen and Lian‐Di Liao and has published in prestigious journals such as The Journal of Pathology, Molecular & Cellular Proteomics and The International Journal of Biochemistry & Cell Biology.

In The Last Decade

Bing Wen

21 papers receiving 299 citations

Peers

Bing Wen
Luguo Sun China
Ashok K. Dilly United States
Yanbo Di China
Jee Hyun Rho South Korea
Sara Bisetto United States
Hwan Hee Lee South Korea
Bing Wen
Citations per year, relative to Bing Wen Bing Wen (= 1×) peers Shuangwei Zhang

Countries citing papers authored by Bing Wen

Since Specialization
Citations

This map shows the geographic impact of Bing Wen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing Wen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing Wen more than expected).

Fields of papers citing papers by Bing Wen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bing Wen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing Wen. The network helps show where Bing Wen may publish in the future.

Co-authorship network of co-authors of Bing Wen

This figure shows the co-authorship network connecting the top 25 collaborators of Bing Wen. A scholar is included among the top collaborators of Bing Wen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bing Wen. Bing Wen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wen, Bing, Qian Tang, Zhi‐Da Zhang, et al.. (2025). Chromatin assembly factor 1 subunit A promotes TLS pathway by recruiting E3 ubiquitin ligase RAD18 in cancer cells. Cell Death and Disease. 16(1). 147–147. 2 indexed citations
2.
Gao, Zhaoming, et al.. (2023). Preoperative small pulmonary nodule localisation using hookwires or coils: strategy selection in adverse events. Journal of Cardiothoracic Surgery. 18(1). 237–237. 1 indexed citations
3.
Li, Chengyu, Bing Wen, Lian‐Di Liao, et al.. (2023). Prenylated PALM2 Promotes the Migration of Esophageal Squamous Cell Carcinoma Cells Through Activating Ezrin. Molecular & Cellular Proteomics. 22(8). 100593–100593. 4 indexed citations
4.
Wen, Bing, Lian‐Di Liao, Zhi‐Da Zhang, et al.. (2023). Co-Expression of Chromatin Assembly Factor 1 Subunit A and Proliferating Cell Nuclear Antigen Is a Prognostic Biomarker of Esophageal Cancer. Biomedicines. 11(4). 1184–1184. 2 indexed citations
5.
Li, Xiang, Liyan Li, Xiaodong Wu, et al.. (2022). Anti‐tumour effects of a macrolide analog F806 in oesophageal squamous cell carcinoma cells by targeting and promoting GLUT1 autolysosomal degradation. FEBS Journal. 289(21). 6782–6798. 3 indexed citations
6.
Zhang, Zhi‐Da, Bing Wen, Xiaodong Wu, et al.. (2022). AKT serine/threonine kinase 2-mediated phosphorylation of fascin threonine 403 regulates esophageal cancer progression. The International Journal of Biochemistry & Cell Biology. 145. 106188–106188. 9 indexed citations
7.
Li, Chongjiao, Bing Wen, Yueli Tian, Jie Chen, & Yong He. (2022). 68Ga-FAPI PET/CT Findings in a Rare Presacral Myxopapillary Ependymoma. Clinical Nuclear Medicine. 47(4). 385–386. 2 indexed citations
8.
Jiao, Jiwei, Sheng Wang, Xiu‐E Xu, et al.. (2022). LOXL2-dependent deacetylation of aldolase A induces metabolic reprogramming and tumor progression. Redox Biology. 57. 102496–102496. 19 indexed citations
9.
Cheng, Yinwei, Fa‐Min Zeng, Shaohong Wang, et al.. (2021). P300/CBP‐associated factor (PCAF)‐mediated acetylation of Fascin at lysine 471 inhibits its actin‐bundling activity and tumor metastasis in esophageal cancer. Cancer Communications. 41(12). 1398–1416. 22 indexed citations
10.
Wu, Yue, et al.. (2021). Berberine Reduces Aβ42 Deposition and Tau Hyperphosphorylation via Ameliorating Endoplasmic Reticulum Stress. Frontiers in Pharmacology. 12. 640758–640758. 40 indexed citations
11.
Wu, Xiaodong, Bing Wen, Wenqi Shi, et al.. (2021). New insights into the function of Fascin in actin bundling: A combined theoretical and experimental study. The International Journal of Biochemistry & Cell Biology. 139. 106056–106056. 8 indexed citations
12.
Zou, Haiying, Bing Wen, Jiwei Jiao, et al.. (2020). Lysyl oxidase-like 2 promotes esophageal squamous cell carcinoma cell migration independent of catalytic activity. The International Journal of Biochemistry & Cell Biology. 125. 105795–105795. 10 indexed citations
13.
Wen, Bing, Li‐Yan Xu, & En‐Min Li. (2020). LOXL2 in cancer: regulation, downstream effectors and novel roles. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1874(2). 188435–188435. 73 indexed citations
14.
Yang, Wei, et al.. (2019). A Clinical Study of Early Intervention with Coralline Hydroxyapatite on Fresh Extraction Sockets. Journal of Nanoscience and Nanotechnology. 19(11). 6956–6960. 2 indexed citations
15.
Li, Ping, et al.. (2019). Imaging findings of ductal carcinoma in situ arising within fibroadenoma. The Breast Journal. 26(5). 1037–1038. 3 indexed citations
16.
Wen, Bing, et al.. (2018). Subventricular zone predicts high velocity of tumor expansion and poor clinical outcome in patients with low grade astrocytoma. Clinical Neurology and Neurosurgery. 168. 12–17. 7 indexed citations
17.
Hang, Weijian, Jiehui Chen, Bing Wen, et al.. (2018). Berberine Ameliorates High Glucose-Induced Cardiomyocyte Injury via AMPK Signaling Activation to Stimulate Mitochondrial Biogenesis and Restore Autophagic Flux. Frontiers in Pharmacology. 9. 1121–1121. 60 indexed citations
19.
Li, Jianguo, Yongxun Zhuansun, Bing Wen, et al.. (2013). Human mesenchymal stem cells elevate CD4+CD25+CD127low/- regulatory T cells of asthmatic patients via heme oxygenase-1.. PubMed. 12(3). 228–35. 14 indexed citations
20.
Li, Jianguo, et al.. (2009). Diagnostic value of transbronchial lung biopsy in peripheral lung cancer. The Chinese-German Journal of Clinical Oncology. 8(10). 592–595. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026